Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rofecoxib vs Diclofenac for Post-Operative Pain in TKR
NCT00140920Phase 4Terminated
- Sponsor
- Merck & Co.
- Start
- May 2004
- Primary completion
- Sep 2004
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of rofecoxib in postoperative pain (3 arms), sponsored by Merck & Co. Primary endpoints: Quantity of patient controlled analgesia and Post-operative morphine administration. Started May 2004; status: terminated.
02
Drugs
rofecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00140920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140920.